| Product ID |
Product Name |
CAS# |
Purity |
| Y3150059 |
5-Pyrimidinecarboxaldehyde, 4-amino-, hydrochloride |
1311254-78-0 |
95% |
| Y1343408 |
Cyclobutanepropanoic acid, -amino-, methyl ester, (S)- |
1251903-81-7 |
97% |
| Y3154965 |
Cyclobutanone, 3-(2-bromoethyl)- |
1379194-44-1 |
95% |
| Y1243935 |
methyl 6-bromo-2-methylnicotinate |
1227562-32-4 |
98% |
| D958694 |
1,2-DibroMo-4-Methoxy-3,5,6-triMethylbenzene |
1359986-20-1 |
98% |
| Y1337649 |
9H-Carbazole-2,7-dicarboxylic acid |
1409971-87-4 |
95% |
| Y3120112 |
1-Amino-8-aza-spiro[4.5]decane-8-carboxylic acid tert-butyl ester |
1357352-82-9 |
98% |
| Y3163008 |
1H-Benzimidazole-6-carbonitrile,2-amino-1-methyl-(9CI) |
141691-42-1 |
95% |
| Y3153134 |
4-Bromomethyl-3,5-difluoro-pyridine |
1227574-15-3 |
95% |
| Y1339744 |
4-Chloro-6-(methylamino)pyrimidine-5-carbaldehyde |
14160-94-2 |
95% |
| D749632 |
4-Methoxyfuro[3,2-d]pyriMidine-6-carboxylic acid |
1431412-19-9 |
95+% |
| Y3150054 |
(R)-1-(Methylamino)-2-propanol HCl |
131101-46-7 |
95% |
| Y3150055 |
bis(4-aminobutyl)(methyl)amine |
127171-38-4 |
95% |
| D958695 |
Benzyl (5-Aminobicyclo[3.2.1]Octan-1-Yl)Carbamate |
1383973-53-2 |
95% |
| Y1243960 |
Methylamino-PEG4-acid |
1283658-71-8 |
95% |
| Y1248348 |
Thiol-PEG7-acid |
1347750-77-9 |
95% |
| Y1054690 |
Azido-PEG1-t-butyl ester |
1374658-85-1 |
95% |
| Y1243970 |
Bromoacetamido-PEG2-Acid |
1415800-44-0 |
95% |
| Y1243971 |
Bis-PEG5-PFP ester |
1334177-78-4 |
95% |
| Y1243987 |
Bromo-PEG6-t-butyl ester |
1393330-41-0 |
97% |
| Y1243847 |
Propargyl-PEG8-alcohol |
1422023-54-8 |
97% |
| D770593 |
t-Boc-N-amido-PEG5-acid |
1347750-78-0 |
97% |
| Y1243988 |
NDMC101 |
1308631-40-4 |
99% |
| Y3307491 |
PF-9184 |
1221971-47-6 |
97% |
| Y1339638 |
VTX-27 |
1321924-70-2 |
99% |
| Y3310345 |
Macitentan D4 |
1258428-05-5 |
98.03% |
| Y3304943 |
neurokinin A (4-10), Tyr(5)-Trp(6,8,9)-Arg(10)- |
126050-12-2 |
99% |
| Y3314196 |
GLP-1 (28-36)amide |
1225021-13-5 |
98.79% |
| Y3157787 |
peptide 78 |
132116-62-2 |
98.13% |
| Y1243974 |
GSK 2033 |
1221277-90-2 |
99% |
| Y1054535 |
KY 05009 |
1228280-29-2 |
95% |
| Y3296497 |
LpxC inhibitor 1a |
1289620-49-0 |
99% |
| Y3315737 |
METHYLSTAT |
1310877-95-2 |
98% |
| Y3105340 |
Lambrolizumab |
1374853-91-4 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assa |
| Y3168317 |
PF 4693627 |
1312815-93-2 |
99% |
| Y3296030 |
PhentolaMine-d4 Hydrochloride |
1346599-65-2 |
95% |
| Y1314655 |
2,3-Dibromo-9H-carbazole |
1356059-56-7 |
98% |
| Y1252629 |
N-([1,1' |
1372778-68-1 |
99% |
| D770594 |
1-NaphthaleneMethanaMine, a-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (aR)- |
1229512-52-0 |
98+% |
| Y1248378 |
L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 1-Methylethyl ester, (P3'),(P'5')-diester with (2'R)-2'-deoxy-2'-fluoro-2'-Methyluridine |
1337482-17-3 |
98% |
| D491306 |
8-chloro-2-(2-(quinolin-2-yl)ethyl)phthalazin-1(2H)-one |
1433204-04-6 |
95% |
| Y1048020 |
7H-Pyrrolo[3,4-b]pyridin-7-one, 3-broMo-5,6-dihydro- |
1346809-61-7 |
98% |
| Y3153866 |
3-fluoro-5-(piperidin-3-yl)pyridine dihydrochloride |
1260864-37-6 |
95% |
| Y1248307 |
(S)-3-(4-Bromophenyl)piperidine |
1335523-82-4 |
95% |
| Y3105169 |
2-bromo-3,6-dichloropyridine |
1266119-41-8 |
95% |
| Y1054318 |
5-(chloroMethyl)-2-(difluoroMethoxy)pyridine |
1211584-92-7 |
95+% |
| Y3105171 |
5-isopropoxy-2-methylbenzoic acid |
1266965-23-4 |
95% |
| Y3157977 |
Acetamide, N-(2-chloro-5-hydroxyphenyl)- |
130647-86-8 |
95% |
| Y3156888 |
Acetamide, N-methyl-2-(4-piperidinyloxy)-, hydrochloride (1 |
1260815-58-4 |
95% |
| Y3153132 |
2-Acetyl-6-nitrobenzoic acid |
13619-70-0 |
95% |
| Y1257035 |
1-(8-Acetyl-quinolin-2-yl)-ethanone |
1214264-82-0 |
97% |
| Y1336770 |
1-Acetyl-piperidine-4-carboxylic acid Methyl ester |
126291-66-5 |
95% |
| Y3150427 |
Alanine, 2-methyl-, 1-methylethyl ester (9CI) |
131322-68-4 |
95% |
| Y3121915 |
albonoursin |
1222-90-8 |
98.0% |
| Y1336833 |
AKOS BC-3144 |
13333-87-4 |
95% |
| D963490 |
all-trans-Retinoic acid sodium salt |
13497-05-7 |
95% |
| Y3290431 |
(alphaS)-alpha-[[(tert-Butoxy)carbonyl]amino]-5-pyrimidinepropanoic acid |
1251904-63-8 |
95%+ |
| Y3150436 |
3-amino-4-(difluoromethoxy)benzonitrile |
1211578-67-4 |
95% |
| Y3150643 |
2-amino-N-[[4-(5-bromopyrimidin-2-yl)oxy-3-chloro-phenyl]carbamoyl]ben zamide |
134742-26-0 |
99.91% |
| Y3150780 |
(5-Amino-2-chloro-pyridin-4-yl)-methanol |
1227583-24-5 |
95% |
| Y3134139 |
2-Amino-N-cyclohexyl-N-methylacetamidehydrochloride |
1220036-32-7 |
95% |
| Y1339681 |
2-Amino-N-(tert-butyl)-2-methylpropanamidehydrochloride |
1220037-14-8 |
97% |
| Y1333501 |
BOC-DL-2'-METHYLPHENYLALANINE, 98 |
139558-50-2 |
97% |
| Y3313781 |
METHYL 2-AMINO-3-(NAPHTHALEN-1-YL)PROPANOATE |
136375-70-7 |
97% |
| Y1247950 |
(1R)-1-(5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)ETHAN-1-AMINE |
1212104-62-5 |
95% |
| Y1322268 |
(2,5-DIBROMOPHENYL)METHANAMINE |
1214331-41-5 |
95% |
| Y3134110 |
(2,6-DIBROMOPHENYL)METHANAMINE HYDROCHLORIDE |
1214323-07-5 |
95% |
| Y1243641 |
(R)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride |
1423040-65-6 |
98% |
| Y1243503 |
(1S)-1-[4-(PROPAN-2-YLOXY)PHENYL]ETHAN-1-AMINE |
1212078-33-5 |
95% |
| Y1340796 |
(1R)-1-(4-FLUORO-2-METHOXYPHENYL)ETHAN-1-AMINE HYDROCHLORIDE |
1354970-56-1 |
95% |
| Y1343734 |
(R)-1-(4-fluorophenyl)butan-1-aMine hydrochloride |
1313593-58-6 |
97% |
| Y1343709 |
(1S)-1-(2,5-DICHLOROPHENYL)ETHANAMINE HYDROCHLORIDE |
1391506-72-1 |
95% |
| Y1243642 |
[1-(2,4-DIMETHYLPHENYL)PROPYL]AMINE HYDROCHLORIDE |
1268982-48-4 |
95% |
| Y3147697 |
[1-(2-BROMOPHENYL)ETHYL](METHYL)AMINE HYDROCHLORIDE |
1423025-56-2 |
95% |
| Y1252321 |
[1-(3,4-DIMETHYLPHENYL)PROPYL]AMINE HYDROCHLORIDE |
1268990-99-3 |
95% |
| D770581 |
Trans-(1S,4S)-4-Boc-aMino-2-Cyclopentene-1-carboxylic acid |
1329035-82-6 |
98+% |
| Y1247958 |
1,3,2-Dioxaborolane, 2-(2-ethoxyethenyl)- 4,4,5,5-tetramethyl- |
1360111-87-0 |
95% |
| Y3291802 |
6-bromo-8-fluoro-1,2,3,4-tetrahydroisoquinoline |
1339780-81-2 |
95% |
| Y3117723 |
cyanidin |
13306-05-3 |
95% |
| Y1343354 |
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide |
1253584-84-7 |
98% |
| Y1328014 |
3,6-dibromo-4,5-difluoro-1,2-phenylenediamine |
1345627-73-7 |
95% |
| Y1248012 |
(S)-1-[(R)-2-[BIS[3,5-BIS(TRIFLUOROMETHYL)PHENYL]PHOSPHINO]-FERROCENYL]ETHYLDI(3,5-XYLYL)PHOSPHINE |
1272317-38-0 |
98% |
| Y1248017 |
4,4'-(2,5-dimethoxy-1,4-phenylene)dipyridine |
1415393-43-9 |
98% |
| Y3315169 |
2,2′-Diamino-4,4′-stilbenedicarboxylic acid |
1275552-69-6 |
95% |
| Y3118010 |
2,3,4,5,6-Pentafluorobenzylphosphonic acid |
137174-84-6 |
97% |
| Y3117999 |
2,4-Bis[4-(N,N-diphenylamino)-2,6-dihydroxyphenyl]squaraine |
1345272-10-7 |
95% |
| Y3293828 |
SALOR-INT L130796-1EA |
134098-68-3 |
97% |
| Y3118112 |
N-[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]-N'-[4-(trifluoroMethyl)phenyl]squaraMide |
1211565-08-0 |
98%,99% ee |
| Y1333521 |
STARBURST(R) (PAMAM) DENDRIMER, GENERATION 1 |
142986-44-5 |
95% |
| Y1333657 |
Sodium 1,1-difluoroethylsulfinate |
1422738-67-7 |
95% |
| Y3292032 |
IPS |
1416821-55-0 |
95% ; |
| Y1265695 |
MIDA021 |
1227700-50-6 |
95% |
| Y3117783 |
Dicyclohexylamine Borane |
131765-96-3 |
95% |
| Y3314704 |
4-(Trimethylsilyl)pyridin-3-yl trifluoromethanesulfonate |
1211583-40-2 |
97% |
| Y3117827 |
Naphtho[1,2-c |
133546-47-1 |
97% |
| Y1314640 |
2-Methylthio-4-trifluoromethylbenzoic acid |
142994-05-6 |
97% |
| Y3107744 |
7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-,(S)- |
139079-42-8 |
98.0% |
| Y3315903 |
(-)-Lyoniresinol 9'-O-glucoside |
143236-02-6 |
98% |
| Y3316570 |
(1S,2R,3R)-1,2,3,4-Tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-2,3-naphthalenedimethanol |
136082-41-2 |
95% |
| D758977 |
(Z)-3-(6-fluoro-1H-indol-3-yl)acrylonitrile |
1350543-67-7 |
95+% |